PDCD1 and neoplasm: In our hands, a suitable volume to start anti-PD-1 therapy with GL261 tumours is ca. 2.1 ± 1.1 mm3, which finally led to the curing of 75% of the animals, allowing ample time for the evaluation of biomarker performance (Section 2.3).